Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists.
ACS Med Chem Lett
; 8(1): 133-137, 2017 Jan 12.
Article
in En
| MEDLINE
| ID: mdl-28105289
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
ACS Med Chem Lett
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
United States